Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 33 min ago
Peer-reviewedLicence not statedClinical lymphoma, myeloma & leukemia

SOHO State of the Art Updates and Next Questions | The Evolving AML Treatment Paradigm

  1. 1Leukemia Program, Massachusetts General Hospital, Mass General Brigham Cancer Institute, Boston, MA, 02114, USA
  2. 2Harvard Medical School, Boston, MA, 02115, USA

Related

  1. Permissive Cardiotoxicity: An Evolving Paradigm
    David L. Madnick, Elizabeth Hutchins, Ashley F. Stein‐Merlob +1
    Journal of the American Heart AssociationPeer-reviewedCC BY-NC-NDCardiovascular medicineCrossref
  2. Maternal–Fetal Oncology Intelligence: Self-Evolving Foundation Models and Digital Twin Ecosystems for Precision Cancer Prediction, Treatment Optimization, and Maternal–Fetal Outcome Forecasting
    International Journal of Drug Delivery TechnologyPeer-reviewedLicence not statedFull text14 citedEpidemiology & public healthOpenAlex
  3. Rethinking the concept of disease modification in an evolving Parkinson's disease treatment landscape
    Angelo Antonini, Robert E Gross, Maria De Leon +8
    Journal of Parkinson’s DiseasePeer-reviewedCC BYFull textNeurologyDOAJ
  4. Combination of antibody–drug conjugates with immunotherapy: a new paradigm in cancer treatment
    Yongli Lai, Ruyu Qin, Zhaidong Liu
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyCrossref
  5. Just-in-Time Neuromodulation: A Precision, State-Dependent Paradigm for On-Demand Brain Intervention
    Ashkan Rashedi, Aref Pariz, Jing Jin +3
    PsyArXivPreprintCC BY 4.0Full textNeurosciencePsychiatry & mental healthOSF
BibTeX
@article{olesinski2026soho,
  title = {{SOHO State of the Art Updates and Next Questions | The Evolving AML Treatment Paradigm}},
  author = {Elyse A. Olesinski and Brandon J. Aubrey and Amir T. Fathi},
  journal = {Clinical lymphoma, myeloma \& leukemia},
  year = {2026},
  month = sep,
  doi = {10.1016/j.clml.2026.09.016},
  url = {https://doi.org/10.1016/j.clml.2026.09.016},
}
RIS
TY  - JOUR
TI  - SOHO State of the Art Updates and Next Questions | The Evolving AML Treatment Paradigm
AU  - Elyse A. Olesinski
AU  - Brandon J. Aubrey
AU  - Amir T. Fathi
PY  - 2026
DA  - 2026/09/25
JO  - Clinical lymphoma, myeloma & leukemia
DO  - 10.1016/j.clml.2026.09.016
UR  - https://doi.org/10.1016/j.clml.2026.09.016
SN  - 2152-2650
SN  - 2152-2669
ER  -